One of the largest randomized trials ever conducted will be the first to evaluate a bivalent respiratory syncytial virus (RSV) prefusion F protein–based vaccine (RSVpreF) for effectiveness in preventing RSV hospitalizations in adults 60 years and older.
Heather Knox is a Digital Producer at KSFY-TV. She specializes in court proceedings, public education, and school administration, often intersecting these themes with her insights on event management software. Heather's work has been featured in KSFY-TV, KTTC NBC 10, FOX2548 & WIProud, WEAU 13 News, Wsaw-tv, and DocWire News.



